MACC1 is highly expressed in GBM, and miR-598 was found to have a direct impact on inhibition of proliferation and invasion through MACC1.24 This suggests that in HGG patients, including GBM, lower levels of miR-598 will be detected compared to LGG due to its natural inhibitive nature. Here, MACC1 is linked to glioblastoma.